BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 2536980)

  • 1. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability.
    Irmiere AF; Manos MM; Jacobson JG; Gibbs JS; Coen DM
    Virology; 1989 Feb; 168(2):210-20. PubMed ID: 2536979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Mechanism of Acyclovir Resistance in Herpes Simplex Virus 1, Which Has a UAG Stop Codon between the First and Second AUG Initiation Codons.
    Nguyen PHA; Yamada S; Shibamura M; Inagaki T; Fujii H; Harada S; Fukushi S; Mizuguchi M; Saijo M
    Jpn J Infect Dis; 2020 Nov; 73(6):447-451. PubMed ID: 32611982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2.
    Balzarini J; Bohman C; De Clercq E
    J Biol Chem; 1993 Mar; 268(9):6332-7. PubMed ID: 8384209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.
    Hwang CB; Horsburgh B; Pelosi E; Roberts S; Digard P; Coen DM
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5461-5. PubMed ID: 8202508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of pyrimidine deoxyribonucleoside kinase (thymidine kinase) and thymidylate kinase as a multifunctional enzyme in cells transformed by herpes simplex virus type 1 and in cells infected with mutant strains of herpes simplex virus.
    Chen MS; Summers WP; Walker J; Summers WC; Prusoff WH
    J Virol; 1979 Jun; 30(3):942-5. PubMed ID: 225551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.
    Pan D; Coen DM
    J Virol; 2012 Apr; 86(8):4518-26. PubMed ID: 22301158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of nucleoside analogs by equine herpesvirus type 1 pyrimidine deoxyribonucleoside kinase.
    Kit S; Ichimura H; De Clercq E
    Antiviral Res; 1987 Jan; 7(1):53-67. PubMed ID: 3026247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.
    Besecker MI; Furness CL; Coen DM; Griffiths A
    J Virol; 2007 Aug; 81(15):8356-60. PubMed ID: 17522225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus resistance to antiviral drugs.
    Morfin F; Thouvenot D
    J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
    Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
    Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
    Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.